Skip to main content

Doximity Announces Fourth Quarter and Fiscal Year 2025 Financial Results

Q4 total revenues of $138.3 million, up 17% year-over-year

Q4 operating cash flow of $98.5 million, up 54% year-over-year

Q4 free cash flow of $97.0 million, up 56% year-over-year

Fiscal year 2025 total revenues of $570.4 million, up 20% year-over-year

Fiscal year 2025 operating cash flow of $273.3 million, up 48% year-over-year

Fiscal year 2025 free cash flow of $266.7 million, up 50% year-over-year

Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced results of its fiscal 2025 fourth quarter and fiscal year ended March 31, 2025.

“We closed out fiscal 2025 on a high note, with record engagement, strong profits, and 20% annual revenue growth,” said Jeff Tangney, co-founder and CEO of Doximity. “Our newsfeed, workflow, and AI tools all hit fresh highs in Q4, helping doctors save time and provide the best care for their patients.”

Fiscal 2025 Fourth Quarter Financial Highlights

All comparisons, unless otherwise noted, are to the three months ended March 31, 2024.

  • Revenue: Revenue of $138.3 million, versus $118.1 million, an increase of 17% year-over-year. Subscription revenue of $131.9 million, versus $112.7 million, an increase of 17% year-over-year.
  • Net income and non-GAAP net income: Net income of $62.5 million, versus $40.6 million, representing a margin of 45.2%, versus 34.4%. Non-GAAP net income of $77.7 million, versus $51.0 million, representing a margin of 56.2%, versus 43.2%.
  • Adjusted EBITDA: Adjusted EBITDA of $69.7 million, versus $56.4 million, an increase of 24% year-over-year, representing adjusted EBITDA margins of 50.4%, versus 47.8%.
  • Diluted net income per share and non-GAAP diluted net income per share: Diluted net income per share was $0.31, versus $0.20, while non-GAAP diluted net income per share was $0.38, versus $0.25.
  • Operating cash flow and free cash flow: Operating cash flow of $98.5 million, versus $63.9 million, an increase of 54% year-over-year, and free cash flow of $97.0 million, versus $62.3 million, an increase of 56% year-over-year.

Fiscal Year 2025 Financial Highlights

All comparisons, unless otherwise noted, are to the fiscal year ended March 31, 2024.

  • Revenue: Revenue of $570.4 million, versus $475.4 million, an increase of 20% year-over-year. Subscription revenue of $543.8 million, versus $450.1 million, an increase of 21% year-over-year.
  • Net income and non-GAAP net income: Net income of $223.2 million, versus $147.6 million, representing a margin of 39.1%, versus 31.0%. Non-GAAP net income of $286.1 million, versus $195.6 million, representing a margin of 50.2%, versus 41.2%.
  • Adjusted EBITDA: Adjusted EBITDA of $313.8 million, versus $230.5 million, an increase of 36% year-over-year, representing adjusted EBITDA margins of 55.0%, versus 48.5%.
  • Diluted net income per share and non-GAAP diluted net income per share: Diluted net income per share was $1.11, versus $0.72, while non-GAAP diluted net income per share was $1.42, versus $0.95.
  • Operating cash flow and free cash flow: Operating cash flow of $273.3 million, versus $184.1 million, an increase of 48% year-over-year, and free cash flow of $266.7 million, versus $178.3 million, an increase of 50% year-over-year.

Financial Outlook

Doximity is providing guidance for its fiscal first quarter ending June 30, 2025 as follows:

  • Revenue between $139 million and $140 million.
  • Adjusted EBITDA between $71 million and $72 million.

Doximity is providing guidance for its fiscal year ending March 31, 2026 as follows:

  • Revenue between $619 million and $631 million.
  • Adjusted EBITDA between $333 million and $345 million.

Conference Call Information

Doximity posted prepared remarks on its investor relations website at https://investors.doximity.com. Doximity will host a webcast today at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) to discuss these financial results. To listen to a live audio webcast, please visit the Company’s Investor Relations page at https://investors.doximity.com. The archived webcast will be available on the Company’s Investor Relations page shortly after the call.

About Doximity

Founded in 2010, Doximity is the leading digital platform for U.S. medical professionals. The company's network members include more than 80% of U.S. physicians across all specialties and practice areas. Doximity provides its verified clinical membership with digital tools built for medicine, enabling them to collaborate with colleagues, stay up to date with the latest medical news and research, manage their careers and on-call schedules, streamline documentation and administrative paperwork, and conduct virtual patient visits. Doximity's mission is to help doctors be more productive so they can provide better care for their patients.

Forward-Looking Statements

Statements we make in this press release may include statements which are not historical facts and are considered forward-looking within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act, which are usually identified by the use of words such as “anticipates,” “believes,” “estimates,” “expects,” “intends,” “may,” “plans,” “projects,” “seeks,” “should,” “will,” and variations of such words or similar expressions. We intend these forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in Section 27A of the Securities Act and Section 21E of the Securities Exchange Act and are making this statement for purposes of complying with those safe harbor provisions. These forward-looking statements reflect our current views about our plans, intentions, expectations, strategies and prospects, which are based on the information currently available to us and on assumptions we have made. Although we believe that our plans, intentions, expectations, strategies and prospects as reflected in or suggested by those forward-looking statements are reasonable, we can give no assurance that the plans, intentions, expectations, or strategies will be attained or achieved. Furthermore, actual results may differ materially from those described in the forward-looking statements and will be affected by a variety of risks and factors including (i) the timing and scope of anticipated stock repurchases; (ii) the impact of uncertainty in the current economic environment and macroeconomic uncertainty; (iii) our ability to retain existing members or add new members to our platform and maintain or grow their engagement with our platform; (iv) our ability to attract new customers or retain existing customers; (v) the impact of our prioritization of our members’ interests; (vi) breaches in our security measures or unauthorized access to members’ data; (vii) our ability to maintain or manage our growth, and other risks and factors that are beyond our control including, without limitation, those set forth in the section entitled “Risk Factors” in the Quarterly Report on Form 10-Q for the fiscal quarter ended December 31, 2024. Additional information will be provided in our Annual Report on Form 10-K for the fiscal year ended March 31, 2025. Moreover, we operate in a very competitive and rapidly changing environment. New risks and uncertainties emerge from time to time, and it is not possible for us to predict all risks and uncertainties that could cause actual results to differ materially from those contained in our forward-looking statements. The forward-looking statements made in this press release relate only to management’s beliefs and assumptions as of this date. We assume no obligation to update publicly any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

DOXIMITY, INC.

CONSOLIDATED BALANCE SHEETS

(in thousands)

 

(unaudited)

 

 

March 31, 2025

 

March 31, 2024

Assets

 

 

 

Current assets:

 

 

 

Cash and cash equivalents

$

209,614

 

$

96,785

 

Marketable securities

 

706,050

 

 

 

666,115

 

Accounts receivable, net

 

128,354

 

 

 

101,332

 

Prepaid expenses and other current assets

 

44,602

 

 

 

48,709

 

Total current assets

 

1,088,620

 

 

 

912,941

 

Property and equipment, net

 

13,656

 

 

 

12,318

 

Deferred income tax assets

 

60,014

 

 

 

45,068

 

Operating lease right-of-use assets

 

8,886

 

 

 

12,332

 

Intangible assets, net

 

23,072

 

 

 

27,317

 

Goodwill

 

67,940

 

 

 

67,940

 

Other assets

 

2,121

 

 

 

1,458

 

Total assets

$

1,264,309

 

 

$

1,079,374

 

Liabilities and Stockholders’ Equity

 

 

 

Current liabilities:

 

 

 

Accounts payable

$

1,356

 

 

$

2,253

 

Accrued expenses and other current liabilities

 

38,405

 

 

 

43,703

 

Deferred revenue, current

 

114,285

 

 

 

99,145

 

Operating lease liabilities, current

 

2,211

 

 

 

2,149

 

Total current liabilities

 

156,257

 

 

 

147,250

 

Deferred revenue, non-current

 

280

 

 

 

211

 

Operating lease liabilities, non-current

 

10,185

 

 

 

12,397

 

Contingent earn-out consideration liability, non-current

 

5,579

 

 

 

10,895

 

Other liabilities, non-current

 

9,383

 

 

 

7,224

 

Total liabilities

 

181,684

 

 

 

177,977

 

Stockholders' Equity

 

 

 

Preferred stock

 

 

 

 

 

Common stock

 

189

 

 

 

187

 

Additional paid-in capital

 

894,225

 

 

 

823,885

 

Accumulated other comprehensive income (loss)

 

1,323

 

 

 

(2,664

)

Retained earnings

 

186,888

 

 

 

79,989

 

Total stockholders' equity

 

1,082,625

 

 

 

901,397

 

Total liabilities and stockholders’ equity

$

1,264,309

 

 

$

1,079,374

 

DOXIMITY, INC.

CONSOLIDATED STATEMENTS OF OPERATIONS

(in thousands, except per share data)

(unaudited)

 

 

Three Months Ended

March 31,

 

Fiscal Year Ended

March 31,

 

2025

 

2024

 

2025

 

2024

Revenue

$

138,288

 

 

$

118,057

 

$

570,399

 

$

475,422

Cost of revenue(1)

 

14,467

 

 

 

12,567

 

 

 

55,874

 

 

 

50,669

 

Gross profit

 

123,821

 

 

 

105,490

 

 

 

514,525

 

 

 

424,753

 

Operating expenses(1):

 

 

 

 

 

 

 

Research and development

 

24,803

 

 

 

20,148

 

 

 

93,038

 

 

 

81,983

 

Sales and marketing

 

37,611

 

 

 

33,517

 

 

 

145,713

 

 

 

133,129

 

General and administrative

 

12,727

 

 

 

9,973

 

 

 

45,670

 

 

 

37,827

 

Restructuring and impairment charges

 

 

 

 

 

 

 

2,304

 

 

 

7,936

 

Total operating expenses

 

75,141

 

 

 

63,638

 

 

 

286,725

 

 

 

260,875

 

Income from operations

 

48,680

 

 

 

41,852

 

 

 

227,800

 

 

 

163,878

 

Other income, net

 

9,714

 

 

 

6,101

 

 

 

35,774

 

 

 

21,324

 

Income before income taxes

 

58,394

 

 

 

47,953

 

 

 

263,574

 

 

 

185,202

 

Provision for (benefit from) income taxes

 

(4,064

)

 

 

7,335

 

 

 

40,389

 

 

 

37,620

 

Net income

$

62,458

 

 

$

40,618

 

 

$

223,185

 

 

$

147,582

 

Net income per share attributable to Class A and Class B common stockholders:

 

 

 

 

 

 

 

Basic

$

0.33

 

 

$

0.22

 

 

$

1.19

 

 

$

0.78

 

Diluted

$

0.31

 

 

$

0.20

 

 

$

1.11

 

 

$

0.72

 

Weighted-average shares used in computing net income per share attributable to Class A and Class B common stockholders:

 

 

 

 

 

 

 

Basic

 

188,362

 

 

 

186,756

 

 

 

186,841

 

 

 

190,172

 

Diluted

 

202,987

 

 

 

201,110

 

 

 

201,208

 

 

 

205,734

 

(1) Cost of revenue and operating expenses include stock-based compensation expense as follows (in thousands):

 

 

Three Months Ended

March 31,

 

Fiscal Year Ended

March 31,

 

2025

 

2024

 

2025

 

2024

Cost of revenue

$

2,628

 

$

2,274

 

$

11,001

 

$

9,479

Research and development

 

4,792

 

 

 

3,104

 

 

 

19,394

 

 

 

11,978

 

Sales and marketing

 

6,442

 

 

 

4,105

 

 

 

26,323

 

 

 

16,857

 

General and administrative

 

4,198

 

 

 

2,374

 

 

 

15,668

 

 

 

9,116

 

Restructuring

 

 

 

 

 

 

 

 

 

 

3,646

 

Total stock-based compensation expense

$

18,060

 

 

$

11,857

 

 

$

72,386

 

 

$

51,076

 

DOXIMITY, INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS

(in thousands)

 

(unaudited)

 

 

Three Months Ended

March 31,

 

Fiscal Year Ended

March 31,

 

2025

 

2024

 

2025

 

2024

Cash flows from operating activities

 

 

 

 

 

 

 

Net income

$

62,458

 

 

$

40,618

 

 

$

223,185

 

 

$

147,582

 

Adjustments to reconcile net income to net cash provided by operating activities:

 

 

 

 

 

 

 

Depreciation and amortization

 

2,829

 

 

 

2,548

 

 

 

10,659

 

 

 

10,265

 

Deferred income taxes

 

(13,788

)

 

 

(8,593

)

 

 

(11,592

)

 

 

(8,593

)

Stock-based compensation, net of amounts capitalized

 

18,060

 

 

 

11,857

 

 

 

72,386

 

 

 

51,076

 

Non-cash lease expense

 

446

 

 

 

475

 

 

 

1,838

 

 

 

2,074

 

Accretion of discount on marketable securities, net

 

(2,919

)

 

 

(1,761

)

 

 

(11,655

)

 

 

(5,238

)

Amortization of deferred contract costs

 

3,423

 

 

 

2,593

 

 

 

9,967

 

 

 

8,871

 

Impairment of long-lived assets

 

 

 

 

 

 

 

2,304

 

 

 

 

Other

 

(19

)

 

 

956

 

 

 

270

 

 

 

2,583

 

Changes in operating assets and liabilities:

 

 

 

 

 

 

 

Accounts receivable

 

9,258

 

 

 

(4,516

)

 

 

(27,206

)

 

 

3,993

 

Prepaid expenses and other assets

 

(18,489

)

 

 

(16,502

)

 

 

2,762

 

 

 

(20,483

)

Deferred contract costs

 

(2,982

)

 

 

(1,683

)

 

 

(12,051

)

 

 

(8,608

)

Accounts payable, accrued expenses and other liabilities

 

(4,535

)

 

 

5,966

 

 

 

(663

)

 

 

8,332

 

Deferred revenue

 

45,295

 

 

 

32,496

 

 

 

15,210

 

 

 

(6,080

)

Operating lease liabilities

 

(550

)

 

 

(510

)

 

 

(2,149

)

 

 

(1,678

)

Net cash provided by operating activities

 

98,487

 

 

 

63,944

 

 

 

273,265

 

 

 

184,096

 

Cash flows from investing activities

 

 

 

 

 

 

 

Purchases of property and equipment

 

 

 

 

 

 

 

 

 

 

(147

)

Internal-use software development costs

 

(1,507

)

 

 

(1,634

)

 

 

(6,525

)

 

 

(5,654

)

Purchases of marketable securities

 

(143,724

)

 

 

(191,529

)

 

 

(675,557

)

 

 

(472,867

)

Maturities of marketable securities

 

118,180

 

 

 

116,993

 

 

 

635,401

 

 

 

435,179

 

Sales of marketable securities

 

2,578

 

 

 

 

 

 

17,383

 

 

 

74,675

 

Net cash provided by (used in) investing activities

 

(24,473

)

 

 

(76,170

)

 

 

(29,298

)

 

 

31,186

 

Cash flows from financing activities

 

 

 

 

 

 

 

Proceeds from issuance of common stock upon exercise of stock options and common stock warrants

 

5,827

 

 

 

3,134

 

 

 

19,732

 

 

 

12,892

 

Proceeds from issuance of common stock in connection with the employee stock purchase plan

 

2,147

 

 

 

1,952

 

 

 

3,569

 

 

 

3,446

 

Taxes paid related to net share settlement of equity awards

 

(10,856

)

 

 

(1,424

)

 

 

(27,185

)

 

 

(6,756

)

Repurchase of common stock

 

(26,788

)

 

 

(17,740

)

 

 

(120,293

)

 

 

(280,716

)

Payment of contingent consideration related to a business combination

 

 

 

 

 

 

 

(5,470

)

 

 

(5,390

)

Payment of excise taxes on share repurchases

 

 

 

 

 

 

 

(1,491

)

 

 

 

Net cash used in financing activities

 

(29,670

)

 

 

(14,078

)

 

 

(131,138

)

 

 

(276,524

)

Net increase (decrease) in cash and cash equivalents

 

44,344

 

 

 

(26,304

)

 

 

112,829

 

 

 

(61,242

)

Cash and cash equivalents, beginning of period

 

165,270

 

 

 

123,089

 

 

 

96,785

 

 

 

158,027

 

Cash and cash equivalents, end of period

$

209,614

 

 

$

96,785

 

 

$

209,614

 

 

$

96,785

 

Supplemental disclosures of cash flow information

 

 

 

 

 

 

 

Cash paid for taxes, net of refunds

$

19,840

 

 

$

12,911

 

 

$

55,654

 

 

$

51,274

 

Non-GAAP Financial Measures

To supplement our consolidated financial statements, which are prepared and presented in accordance with accounting principles generally accepted in the United States (“GAAP”), the Company uses the following non-GAAP measures of financial performance:

  • Non-GAAP gross profit, non-GAAP gross margin, non-GAAP operating income, non-GAAP net income, non-GAAP net income margin, and non-GAAP basic and diluted net income per common share: We exclude the effect of stock-based compensation expense, amortization of acquired intangible assets, change in fair value of contingent earn-out consideration liability, and restructuring and impairment charges from non-GAAP gross profit, non-GAAP gross margin and non-GAAP operating income. Non-GAAP net income and non-GAAP net income margin are further adjusted for estimated income tax on such adjustments. We calculate income taxes on the adjustments by applying an estimated annual effective tax rate to the adjustments. Non-GAAP basic and diluted net income per common share is non-GAAP net income attributable to common stockholders divided by the weighted average number of shares. For both basic and diluted non-GAAP net income per share, the weighted average shares we use in computing non-GAAP net income per share is equal to our GAAP weighted average shares. Non-GAAP gross margin represents non-GAAP gross profit as a percentage of revenue and non-GAAP net income margin represents non-GAAP net income as a percentage of revenue.
  • Adjusted EBITDA and adjusted EBITDA margin: We define adjusted EBITDA as net income before interest, income taxes, depreciation, and amortization, and as further adjusted for stock-based compensation expense, change in fair value of contingent earn-out consideration liability, restructuring and impairment charges, and other income, net. Net income margin represents net income as a percentage of revenue and adjusted EBITDA margin represents adjusted EBITDA as a percentage of revenue.
  • Free cash flow: We calculate free cash flow as cash flow from operating activities less purchases of property and equipment and internal-use software development costs.

We use these non-GAAP financial measures internally for financial and operational decision-making purposes and as a means to evaluate period-to-period comparisons. Non-GAAP financial measures are not meant to be considered in isolation or as a substitute for comparable GAAP financial measures and should be read only in conjunction with our consolidated financial statements prepared in accordance with GAAP. Our presentation of non-GAAP financial measures may not be comparable to similar measures used by other companies. We encourage investors to carefully consider our results under GAAP, as well as our supplemental non-GAAP information and the reconciliation between these presentations, to more fully understand our business. Please see the tables included at the end of this release for the reconciliation of GAAP to non-GAAP results.

Key Business Metrics

  • Net revenue retention rate: Net revenue retention rate is calculated by taking the trailing 12-month (“TTM”) subscription-based revenue from our customers that had revenue in the prior TTM period and dividing that by the total subscription-based revenue for the prior TTM period. For the purposes of this calculation, subscription revenue excludes subscriptions for individuals and small practices and other non-recurring items. Our net revenue retention rate compares our subscription revenue from the same set of customers across comparable periods, and reflects customer renewals, expansion, contraction, and churn. Our net revenue retention rate is directly tied to our revenue growth rate and thus fluctuates as that growth rate fluctuates.
  • Customers with trailing 12-month subscription revenue greater than $500,000: The number of customers with TTM subscription revenue greater than $500,000 is a key indicator of the scale of our business, and is calculated by counting the number of customers that contributed more than $500,000 in subscription revenue in the TTM period. Our customer count is subject to adjustments for acquisitions, consolidations, spin-offs, and other market activity, and we present our total customer count for historical periods reflecting these adjustments.

Reconciliation of GAAP to Non-GAAP Financial Measures

The following tables reconcile the specific items excluded from GAAP metrics in the calculation of non-GAAP metrics for the periods shown below:

 

Three Months Ended

March 31,

 

Fiscal Year Ended

March 31,

 

2025

 

2024

 

2025

 

2024

 

(unaudited)

 

(in thousands, except percentages)

Net income

$

62,458

 

 

$

40,618

 

 

$

223,185

 

 

$

147,582

 

Adjusted to exclude the following:

 

 

 

 

 

 

 

Stock-based compensation

 

18,060

 

 

 

11,857

 

 

 

72,386

 

 

 

47,430

 

Depreciation and amortization

 

2,829

 

 

 

2,548

 

 

 

10,659

 

 

 

10,265

 

Provision for (benefit from) income taxes

 

(4,064

)

 

 

7,335

 

 

 

40,389

 

 

 

37,620

 

Restructuring and impairment charges

 

 

 

 

 

 

 

2,304

 

 

 

7,936

 

Change in fair value of contingent earn-out consideration liability

 

167

 

 

 

183

 

 

 

680

 

 

 

951

 

Other income, net

 

(9,714

)

 

 

(6,101

)

 

 

(35,774

)

 

 

(21,324

)

Adjusted EBITDA

$

69,736

 

 

$

56,440

 

 

$

313,829

 

 

$

230,460

 

 

 

 

 

 

 

 

 

Revenue

$

138,288

 

 

$

118,057

 

 

$

570,399

 

 

$

475,422

 

Net income margin

 

45.2

%

 

 

34.4

%

 

 

39.1

%

 

 

31.0

%

Adjusted EBITDA margin

 

50.4

%

 

 

47.8

%

 

 

55.0

%

 

 

48.5

%

 

Three Months Ended

March 31,

 

Fiscal Year Ended

March 31,

 

2025

 

2024

 

2025

 

2024

 

(unaudited)

 

(in thousands)

Net cash provided by operating activities

$

98,487

 

 

$

63,944

 

 

$

273,265

 

 

$

184,096

 

Purchases of property and equipment

 

 

 

 

 

 

 

 

 

 

(147

)

Internal-use software development costs

 

(1,507

)

 

 

(1,634

)

 

 

(6,525

)

 

 

(5,654

)

Free cash flow

$

96,980

 

 

$

62,310

 

 

$

266,740

 

 

$

178,295

 

Other cash flow components:

 

 

 

 

 

 

 

Net cash provided by (used in) investing activities

$

(24,473

)

 

$

(76,170

)

 

$

(29,298

)

 

$

31,186

 

Net cash used in financing activities

$

(29,670

)

 

$

(14,078

)

 

$

(131,138

)

 

$

(276,524

)

 

Three Months Ended

March 31,

 

Fiscal Year Ended

March 31,

 

2025

 

2024

 

2025

 

2024

 

(unaudited)

 

(in thousands, except per share data and percentages)

GAAP cost of revenue

$

14,467

 

 

$

12,567

 

 

$

55,874

 

 

$

50,669

 

Adjusted to exclude the following:

 

 

 

 

 

 

 

Stock-based compensation

 

(2,628

)

 

 

(2,274

)

 

 

(11,001

)

 

 

(9,479

)

Amortization of acquired intangibles

 

 

 

 

 

 

 

 

 

 

(274

)

Non-GAAP cost of revenue

$

11,839

 

 

$

10,293

 

 

$

44,873

 

 

$

40,916

 

 

 

 

 

 

 

 

 

GAAP gross profit

$

123,821

 

 

$

105,490

 

 

$

514,525

 

 

$

424,753

 

Adjusted to exclude the following:

 

 

 

 

 

 

 

Stock-based compensation

 

2,628

 

 

 

2,274

 

 

 

11,001

 

 

 

9,479

 

Amortization of acquired intangibles

 

 

 

 

 

 

 

 

 

 

274

 

Non-GAAP gross profit

$

126,449

 

 

$

107,764

 

 

$

525,526

 

 

$

434,506

 

 

 

 

 

 

 

 

 

GAAP gross margin

 

89.5

%

 

 

89.4

%

 

 

90.2

%

 

 

89.3

%

Non-GAAP gross margin

 

91.4

%

 

 

91.3

%

 

 

92.1

%

 

 

91.4

%

 

 

 

 

 

 

 

 

GAAP research and development expense

$

24,803

 

 

$

20,148

 

 

$

93,038

 

 

$

81,983

 

Adjusted to exclude the following:

 

 

 

 

 

 

 

Stock-based compensation

 

(4,792

)

 

 

(3,104

)

 

 

(19,394

)

 

 

(11,978

)

Non-GAAP research and development expense

$

20,011

 

 

$

17,044

 

 

$

73,644

 

 

$

70,005

 

 

 

 

 

 

 

 

 

GAAP sales and marketing expense

$

37,611

 

 

$

33,517

 

 

$

145,713

 

 

$

133,129

 

Adjusted to exclude the following:

 

 

 

 

 

 

 

Stock-based compensation

 

(6,442

)

 

 

(4,105

)

 

 

(26,323

)

 

 

(16,857

)

Amortization of acquired intangibles

 

(1,061

)

 

 

(1,061

)

 

 

(4,244

)

 

 

(4,244

)

Change in fair value of contingent earn-out consideration liability

 

(167

)

 

 

(183

)

 

 

(680

)

 

 

(951

)

Non-GAAP sales and marketing expense

$

29,941

 

 

$

28,168

 

 

$

114,466

 

 

$

111,077

 

 

 

 

 

 

 

 

 

GAAP general and administrative expense

$

12,727

 

 

$

9,973

 

 

$

45,670

 

 

$

37,827

 

Adjusted to exclude the following:

 

 

 

 

 

 

 

Stock-based compensation

 

(4,198

)

 

 

(2,374

)

 

 

(15,668

)

 

 

(9,116

)

Non-GAAP general and administrative expense

$

8,529

 

 

$

7,599

 

 

$

30,002

 

 

$

28,711

 

 

 

 

 

 

 

 

 

GAAP operating expense

$

75,141

 

 

$

63,638

 

 

$

286,725

 

 

$

260,875

 

Adjusted to exclude the following:

 

 

 

 

 

 

 

Stock-based compensation

 

(15,432

)

 

 

(9,583

)

 

 

(61,385

)

 

 

(37,951

)

Amortization of acquired intangibles

 

(1,061

)

 

 

(1,061

)

 

 

(4,244

)

 

 

(4,244

)

Change in fair value of contingent earn-out consideration liability

 

(167

)

 

 

(183

)

 

 

(680

)

 

 

(951

)

Restructuring and impairment charges

 

 

 

 

 

 

 

(2,304

)

 

 

(7,936

)

Non-GAAP operating expense

$

58,481

 

 

$

52,811

 

 

$

218,112

 

 

$

209,793

 

 

 

 

 

 

 

 

 

GAAP operating income

$

48,680

 

 

$

41,852

 

 

$

227,800

 

 

$

163,878

 

Adjusted to exclude the following:

 

 

 

 

 

 

 

Stock-based compensation

 

18,060

 

 

 

11,857

 

 

 

72,386

 

 

 

47,430

 

Amortization of acquired intangibles

 

1,061

 

 

 

1,061

 

 

 

4,244

 

 

 

4,518

 

Change in fair value of contingent earn-out consideration liability

 

167

 

 

 

183

 

 

 

680

 

 

 

951

 

Restructuring and impairment charges

 

 

 

 

 

 

 

2,304

 

 

 

7,936

 

Non-GAAP operating income

$

67,968

 

 

$

54,953

 

 

$

307,414

 

 

$

224,713

 

 

 

 

 

 

 

 

 

GAAP net income

$

62,458

 

 

$

40,618

 

 

$

223,185

 

 

$

147,582

 

Adjusted to exclude the following:

 

 

 

 

 

 

 

Stock-based compensation

 

18,060

 

 

 

11,857

 

 

 

72,386

 

 

 

47,430

 

Amortization of acquired intangibles

 

1,061

 

 

 

1,061

 

 

 

4,244

 

 

 

4,518

 

Change in fair value of contingent earn-out consideration liability

 

167

 

 

 

183

 

 

 

680

 

 

 

951

 

Restructuring and impairment charges

 

 

 

 

 

 

 

2,304

 

 

 

7,936

 

Income tax effect of non-GAAP adjustments (1)

 

(4,050

)

 

 

(2,751

)

 

 

(16,719

)

 

 

(12,775

)

Non-GAAP net income

$

77,696

 

 

$

50,968

 

 

$

286,080

 

 

$

195,642

 

Non-GAAP net income margin

 

56.2

%

 

 

43.2

%

 

 

50.2

%

 

 

41.2

%

 

 

 

 

 

 

 

 

Weighted-average shares used in computing net income per share attributable to Class A and Class B common stockholders:

 

 

 

 

 

 

 

Basic

 

188,362

 

 

 

186,756

 

 

 

186,841

 

 

 

190,172

 

Diluted

 

202,987

 

 

 

201,110

 

 

 

201,208

 

 

 

205,734

 

 

 

 

 

 

 

 

 

Non-GAAP net income per share attributable to Class A and Class B stockholders:

 

 

 

 

 

 

 

Basic

$

0.41

 

 

$

0.27

 

 

$

1.53

 

 

$

1.03

 

Diluted

$

0.38

 

 

$

0.25

 

 

$

1.42

 

 

$

0.95

 

 

(1) For the three months and fiscal years ended March 31, 2025 and 2024, management used an estimated annual effective non-GAAP tax rate of 21.0%.

 

Contacts

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.